Aster DM Healthcare Q4 PAT declines 20% yoy to Rs105cr

Aster DM Healthcare Limited, private healthcare service providers in multiple GCC states and emerging healthcare player in India, on Tuesday announced results for the quarter ended March 31, 2021.

The company’s Profit After Tax (Post Non-Controlling Interest) in Q4FY21 increased by 14% qoq to Rs105cr, compared to Rs92cr in Q3FY21 and reduced by 20% yoy, compared to Rs131cr in Q4FY20.

PAT (Pre Non-Controlling Interest) increased by 9% qoq to Rs117cr in Q4FY21, compared to Rs107cr in Q3FY21 and reduced 20% yoy compared to Rs146cr in Q4FY20.

Operating Revenue in Q4FY21 increased by 7% qoq to Rs2,391cr, compared to Rs2,228cr in Q3FY21 and increased by 5% yoy compared to Rs2,280cr in Q4FY20.

EBITDA (excluding other income and fair value put option) increased by 2% qoq to Rs336cr in Q4FY21 compared to Rs328cr in Q3FY21 and reduced by 17% yoy, compared to Rs404cr in Q4FY20.

“The Q4FY21 saw the second wave of Covid for GCC region. The international borders were closed, travel restrictions, night curfews and lockdowns impacted the Hospitals and Pahracies business. Restrictions on electives were imposed and at certain locations like Qatar, our workforce was borrowed by State bodied to meet the pandemic needs.

In India, Q4FY21 witnessed first wave of pandemic receding. Our Hospitals saw increased occupancy and patient visits. This is reflected in our revenues and profitability,” Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare, said.

At around 10.40 am, Aster DM Healthcare Ltd was trading at Rs152.50 per piece down by Rs5.7 or 3.6% from its previous closing of Rs158.20 per piece on the BSE. India Infoline